Global Blood Plasma & Plasma Derived Medicinal Products Market
Description
Global blood plasma & plasma derived medicinal Products market is expected to reach USD 62.66 billion by 2032 from USD 34.88 billion in 2024, growing at a CAGR of 7.65% during the forecast period of 2025 to 2032.
Market Segmentation:
Global Blood Plasma & Plasma Derived Medicinal Products Market, By Product (Immunoglobulins, Coagulation Factors (For Bleeding Disorders), Albumin (Plasma Volume Expander), Protease Inhibitors (For Genetic Deficiencies), Monoclonal Antibodies (Derived From Plasma Cells), and Other Plasma Derived Proteins), Application (Immunology, Hematology, Critical Care, Neurology, Pulmonology, Haemato-Oncology, Rheumatology, and Other Applications), Processing Technology (Ion Exchange Chromatography, Affinity Chromatography, Cryoprecipitation, Ultrafiltration, and Microfiltration), Mode (Modern and Traditional Plasma Fractionation), End-User (Hospitals & Clinics, Research Labs, Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Denmark, Sweden, Belgium, Ireland, Norway, Finland, Rest of Europe, China, Japan, South Korea, Australia, India, Malaysia, Thailand, Singapore, Philippines, Indonesia, New Zealand, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Columbia, Chile, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Bahrain, Kuwait, Oman, Qatar, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2032
Overview of the Global Blood Plasma & Plasma Derived Medicinal Market Dynamics:
Drivers
• Rising prevalence of rare and chronic diseases
• Expanding geriatric population
Restraints
• High cost and complex manufacturing process
• Lack of plasma supply and donor
Opportunities
• Advancements in plasma processing technologies to enhance yield and reduce costs
• Reimbursement frameworks and increased governmental focus on rare disease treatment
Market Players:
The key players operating in the global blood plasma & plasma derived medicinal products market are:
• CSL
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Octapharma AG
• Kedrion
• ADMA Biologics, Inc
• Aegros
• Bharat Serums
• Biotest AG
• Fresenius Kabi AG
• GC Biopharma corporate
• ICHOR
• Intas Pharmaceuticals Ltd.
• Kamada Pharmaceuticals
• KM Biologics
• LFB
• PlasmaGen BioSciences Pvt. Ltd.
• Proliant Health & Biologicals
• Promea
• Reliance Life Sciences
• Sichuan Yuanda Shyuang Pharmaceutical Co., Ltd.
• SK Plasma
• Synthaverse S. A.
• Taibang Bio Group Co., Ltd
• VIRCHOW BIOTECH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Market Segmentation:
Global Blood Plasma & Plasma Derived Medicinal Products Market, By Product (Immunoglobulins, Coagulation Factors (For Bleeding Disorders), Albumin (Plasma Volume Expander), Protease Inhibitors (For Genetic Deficiencies), Monoclonal Antibodies (Derived From Plasma Cells), and Other Plasma Derived Proteins), Application (Immunology, Hematology, Critical Care, Neurology, Pulmonology, Haemato-Oncology, Rheumatology, and Other Applications), Processing Technology (Ion Exchange Chromatography, Affinity Chromatography, Cryoprecipitation, Ultrafiltration, and Microfiltration), Mode (Modern and Traditional Plasma Fractionation), End-User (Hospitals & Clinics, Research Labs, Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Poland, Denmark, Sweden, Belgium, Ireland, Norway, Finland, Rest of Europe, China, Japan, South Korea, Australia, India, Malaysia, Thailand, Singapore, Philippines, Indonesia, New Zealand, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Columbia, Chile, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Bahrain, Kuwait, Oman, Qatar, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2032
Overview of the Global Blood Plasma & Plasma Derived Medicinal Market Dynamics:
Drivers
• Rising prevalence of rare and chronic diseases
• Expanding geriatric population
Restraints
• High cost and complex manufacturing process
• Lack of plasma supply and donor
Opportunities
• Advancements in plasma processing technologies to enhance yield and reduce costs
• Reimbursement frameworks and increased governmental focus on rare disease treatment
Market Players:
The key players operating in the global blood plasma & plasma derived medicinal products market are:
• CSL
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Octapharma AG
• Kedrion
• ADMA Biologics, Inc
• Aegros
• Bharat Serums
• Biotest AG
• Fresenius Kabi AG
• GC Biopharma corporate
• ICHOR
• Intas Pharmaceuticals Ltd.
• Kamada Pharmaceuticals
• KM Biologics
• LFB
• PlasmaGen BioSciences Pvt. Ltd.
• Proliant Health & Biologicals
• Promea
• Reliance Life Sciences
• Sichuan Yuanda Shyuang Pharmaceutical Co., Ltd.
• SK Plasma
• Synthaverse S. A.
• Taibang Bio Group Co., Ltd
• VIRCHOW BIOTECH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
350 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Global Blood Plasma & Plasma Derived Medicinal Products Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestle Analysis
- 4.1.1 Political Factors
- 4.1.2 Economic Factors
- 4.1.3 Social Factors
- 4.1.4 Technological Factors
- 4.1.5 Environmental Factors
- 4.1.6 Legal Factors
- 4.2 Porter’s Five Forces
- 4.2.1 Threat Of New Entrants
- 4.2.2 Bargaining Power Of Suppliers
- 4.2.3 Bargaining Power Of Buyers
- 4.2.4 Threat Of Substitutes
- 4.2.5 Industry Rivalry
- 4.3 Supply Chain Impact On The Global Blood Plasma & Plasma Derived Medicinal Products Market
- 4.3.1 Overview
- 4.3.2 Raw Material Availability
- 4.3.3 Manufacturing Capacity
- 4.3.4 Logistics And Last-mile Hurdles
- 4.3.5 Pricing Models And Market Positioning
- 4.4 Innovation Strategies
- 4.4.1 Key Innovation Strategies
- 4.4.2 Emerging Delivery Techniques
- 4.4.3 Strategic Implications
- 4.4.4 Conclusion
- 4.5 Risk And Mitigation
- 4.6 Vendor Selection Dynamics
- 4.6.1 Product Quality And Regulatory Compliance
- 4.6.2 Supply Chain Capabilities And Reliability
- 4.6.3 Clinical Efficacy And Innovation
- 4.6.4 Cost Competitiveness And Reimbursement Compatibility
- 4.6.5 Local Market Presence And Support Infrastructure
- 4.6.6 Ethical Sourcing, Esg Compliance, And Transparency
- 4.6.7 Conclusion
- 4.7 Tariffs And Their Impact On Market
- 4.7.1 Current Tariff Rates In Top-5 Country Markets
- 4.7.2 Outlook: Local Production V/S Import Reliance
- 4.7.3 Vendor Selection Criteria Dynamics
- 4.7.4 Impact On Supply Chain
- 4.7.5 Impact On Prices
- 4.7.6 Regulatory Inclination
- 4.7.6.1 Gcc Trade Alignment & Ftas
- 4.7.6.2 Special Zones And Re-export Models
- 4.7.6.3 Local Subsidy & Policy Response
- 4.7.6.4 Domestic Course Of Correction
- 5 Regulation Coverage
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Rising Prevalence Of Rare And Chronic Diseases
- 6.1.2 Expanding Geriatric Population
- 6.1.3 Technological Advancements In Plasma Fractionation
- 6.1.4 Government And Institutional Support
- 6.2 Restraints
- 6.2.1 High Cost And Complex Manufacturing Process
- 6.2.2 Lack Of Plasma Supply And Donor
- 6.3 Opportunities
- 6.3.1 Advancements In Plasma Processing Technologies To Enhance Yield And Reduce Costs
- 6.3.2 Reimbursement Frameworks And Increased Governmental Focus On Rare Disease Treatment
- 6.3.3 Strategic Alliances, Mergers, And Acquisitions To Strengthen Global Market Penetration
- 6.4 Challenges
- 6.4.1 Competitive Pressure From Recombinant And Alternative Biological Therapies
- 6.4.2 Infrastructure Limitations In Cold Chain Logistics Impacting Product Distribution
- 7 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Product
- 7.1 Overview
- 7.2 Immunoglobulins
- 7.3 Coagulation Factors (For Bleeding Disorders)
- 7.4 Albumin (Plasma Volume Expander)
- 7.5 Protease Inhibitors (For Genetic Deficiencies)
- 7.6 Monoclonal Antibodies (Derived From Plasma Cells)
- 7.7 Other Plasma Derived Proteins
- 8 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Application
- 8.1 Overview
- 8.2 Immunology
- 8.3 Hematology
- 8.4 Critical Care
- 8.5 Neurology
- 8.6 Pulmonology
- 8.7 Haemato-oncology
- 8.8 Rheumatology
- 8.9 Other Applications
- 9 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Technology
- 9.1 Overview
- 9.2 Ion Exchange Chromatography
- 9.3 Affinity Chromatography
- 9.4 Cryoprecipitation
- 9.5 Ultrafiltration
- 9.6 Microfiltration
- 10 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Mode
- 10.1 Overview
- 10.2 Modern
- 10.3 Traditional Plasma Fractionation
- 11 Global Blood Plasma & Plasma Derived Medicinal Products Market, By End User
- 11.1 Overview
- 11.2 Hospitals & Clinics
- 11.3 Research Labs
- 11.4 Academic Institutes
- 11.5 Others
- 12 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel
- 12.1 Overview
- 12.2 Direct Tenders
- 12.3 Third Party Distributors
- 12.4 Others
- 13 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Region
- 13.1 Overview
- 13.2 North America
- 13.2.1 U.S
- 13.2.2 Canada
- 13.2.3 Mexico
- 13.3 Europe
- 13.3.1 Germany
- 13.3.2 France
- 13.3.3 U.K
- 13.3.4 Italy
- 13.3.5 Spain
- 13.3.6 Russia
- 13.3.7 Turkey
- 13.3.8 Netherlands
- 13.3.9 Switzerland
- 13.3.10 Poland
- 13.3.11 Denmark
- 13.3.12 Sweden
- 13.3.13 Belgium
- 13.3.14 Ireland
- 13.3.15 Norway
- 13.3.16 Finland
- 13.3.17 Rest Of Europe
- 13.4 Asia-pacific
- 13.4.1 China
- 13.4.2 Japan
- 13.4.3 South Korea
- 13.4.4 Australia
- 13.4.5 India
- 13.4.6 Malaysia
- 13.4.7 Thailand
- 13.4.8 Singapore
- 13.4.9 Philippines
- 13.4.10 Indonesia
- 13.4.11 New Zealand
- 13.4.12 Vietnam
- 13.4.13 Taiwan
- 13.4.14 Rest Of Asia-pacific
- 13.5 Middle East And Africa
- 13.5.1 South Africa
- 13.5.2 Saudi Arabia
- 13.5.3 U.A.E.
- 13.5.4 Israel
- 13.5.5 Egypt
- 13.5.6 Bahrain
- 13.5.7 Kuwait
- 13.5.8 Oman
- 13.5.9 Qatar
- 13.5.10 Rest Of Middle East And Africa
- 13.6 South America
- 13.6.1 Brazil
- 13.6.2 Argentina
- 13.6.3 Columbia
- 13.6.4 Chile
- 13.6.5 Peru
- 13.6.6 Rest Of South America
- 14 Global Blood Plasma & Plasma Derived Medicinal Products Market, Company Landscape
- 14.1 Company Share Analysis: Global
- 14.2 Company Share Analysis: North America
- 14.3 Company Share Analysis: Europe
- 14.4 Company Share Analysis: Asia-pacific
- 15 Swot Analysis
- 16 Company Profile
- 16.1 Csl
- 16.1.1 Company Snapshot
- 16.1.2 Revenue Analysis
- 16.1.3 Company Share Analysis
- 16.1.4 Product Portfolio
- 16.1.5 Recent Developments
- 16.2 Takeda Pharmaceutical Company Limited
- 16.2.1 Company Snapshot
- 16.2.2 Revenue Analysis
- 16.2.3 Company Share Analysis
- 16.2.4 Product Portfolio
- 16.2.5 Recent Developments
- 16.3 Grifols, S.A.
- 16.3.1 Company Snapshot
- 16.3.2 Revenue Analysis
- 16.3.3 Company Share Analysis
- 16.3.4 Product Portfolio
- 16.3.5 Recent Developments
- 16.4 Octapharma Ag
- 16.4.1 Company Snapshot
- 16.4.2 Company Share Analysis
- 16.4.3 Product Portfolio
- 16.4.4 Recent Developments
- 16.5 Kedrion
- 16.5.1 Company Snapshot
- 16.5.2 Company Share Analysis
- 16.5.3 Product Portfolio
- 16.5.4 Recent Development
- 16.6 Adma Biologics, Inc
- 16.6.1 Company Snapshot
- 16.6.2 Revenue Analysis
- 16.6.3 Product Portfolio
- 16.6.4 Recent Development
- 16.7 Aegros
- 16.7.1 Company Snapshot
- 16.7.2 Product Portfolio
- 16.7.3 Recent Development
- 16.8 Bharat Serums
- 16.8.1 Company Snapshot
- 16.8.2 Product Portfolio
- 16.8.3 Recent Development
- 16.9 Biotest Ag.
- 16.9.1 Company Snapshot
- 16.9.2 Revenue Analysis
- 16.9.3 Product Portfolio
- 16.9.4 Recent Developments
- 16.10 Fresenius Kabi Ag
- 16.10.1 Company Snapshot
- 16.10.2 Product Portfolio
- 16.10.3 Recent Development
- 16.11 Gc Biopharma Corporate
- 16.11.1 Company Snapshot
- 16.11.2 Revenue Analysis
- 16.11.3 Product Portfolio
- 16.11.4 Recent Development
- 16.12 Ichor
- 16.12.1 Company Snapshot
- 16.12.2 Product Portfolio
- 16.12.3 Recent Development
- 16.13 Intas Pharmaceuticals Ltd.
- 16.13.1 Company Snapshot
- 16.13.2 Product Portfolio
- 16.13.3 Recent Development
- 16.14 Kamada Pharmaceuticals
- 16.14.1 Company Snapshot
- 16.14.2 Revenue Analysis
- 16.14.3 Product Portfolio
- 16.14.4 Recent Development
- 16.15 Km Biologics
- 16.15.1 Company Snapshot
- 16.15.2 Product Portfolio
- 16.15.3 Recent Development
- 16.16 Lfb
- 16.16.1 Company Snapshot
- 16.16.2 Product Portfolio
- 16.16.3 Recent Development
- 16.17 Plasmagen Biosciences Pvt. Ltd.
- 16.17.1 Company Snapshot
- 16.17.2 Product Portfolio
- 16.17.3 Recent Developments
- 16.18 Proliant Health & Biologicals
- 16.18.1 Company Snapshot
- 16.18.2 Product Portfolio
- 16.18.3 Recent Development
- 16.19 Promea
- 16.19.1 Company Snapshot
- 16.19.2 Product Portfolio
- 16.19.3 Recent Development
- 16.20 Reliance Life Sciences
- 16.20.1 Company Snapshot
- 16.20.2 Business Portfolio
- 16.20.3 Recent Development
- 16.21 Sichuan Yuanda Shyuang Pharmaceutical Co., Ltd.
- 16.21.1 Company Snapshot
- 16.21.2 Product Portfolio
- 16.21.3 Recent Development
- 16.22 Sk Plasma
- 16.22.1 Company Snapshot
- 16.22.2 Product Portfolio
- 16.22.3 Recent Development
- 16.23 Synthaverse S. A.
- 16.23.1 Company Snapshot
- 16.23.2 Revenue Analysis
- 16.23.3 Product Portfolio
- 16.23.4 Recent Developments
- 16.24 Taibang Bio Group Co., Ltd
- 16.24.1 Company Snapshot
- 16.24.2 Product Portfolio
- 16.24.3 Recent Development
- 16.25 Virchow Biotech
- 16.25.1 Company Snapshot
- 16.25.2 Product Portfolio
- 16.25.3 Recent Development
- 17 Questionnaire
- 18 Related Reports
- List Of Tables
- Table 1 Regulatory Framework And Guidelines
- Table 2 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 3 Global Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 4 Global Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 5 Global Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 6 Global Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 7 Global Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 8 Global Coagulation Factors In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 9 Global Factor Ix In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 10 Global Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 11 Global Factor Viii In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 12 Global Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 13 Global Fibrinogen In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 14 Global Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 15 Global Von Willebrand Factor (Vwf) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 16 Global Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 17 Global Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 18 In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 19 Global Albumin In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 20 Global Protease Inhibitors (For Genetic Deficiencies)In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 21 Global Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 22 Global Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 23 Global C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 24 Global Monoclonal Antibodies (Derived From Plasma Cells )In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 25 Global Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 26 Global Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 27 Global Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 28 Global Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2025-2032 (Usd Thousand)
- Table 29 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2025-2032 (Usd Thousand)
- Table 30 Global Immunology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 31 Global Hematology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 32 Global Critical Care In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 33 Global Neurology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 34 Global Pulmonology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 35 Global Hematology -oncology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 36 Global Rheumatology In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 37 Global Other Applications In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 38 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Technology, 2025-2032 (Usd Thousand)
- Table 39 Global Ion Exchange Chromatography In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 40 Global Affinity Chromatography In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 41 Global Cryoprecipitation In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 42 Global Ultrafiltration In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 43 Global Microfiltration In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 44 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2025-2032 (Usd Thousand)
- Table 45 Global Modern In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 46 Global Traditional Plasma Fractionation In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 47 Global Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2025-2032 (Usd Thousand)
- Table 48 Global Hospitals & Clinics In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 49 Global Research Labs In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 50 Global Academic Institutes In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 51 Global Others Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 52 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2025-2032 (Usd Thousand)
- Table 53 Global Direct Tenders In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 54 Global Third Party Distributors In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 55 Global Others In Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2025-2032 (Usd Thousand)
- Table 56 Global Blood Plasma & Plasma Derived Medicinal Products Market, By Region, 2018-2032 (Usd Thousand)
- Table 57 North America Blood Plasma & Plasma Derived Medicinal Products Market, By Country, 2018-2032 (Usd Thousand)
- Table 58 North America Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 59 North America Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 60 North America Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 61 North America Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 62 North America Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 63 North America Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 64 North America Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 65 North America Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 66 North America Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 67 North America Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 68 North America Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 69 North America Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 70 North America Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 71 North America Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 72 North America Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 73 North America Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 74 North America Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 75 North America C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 76 North America Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 77 North America Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 78 North America Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 79 North America Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 80 North America Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 81 North America Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 82 North America Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 83 North America Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 84 U.S. Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 85 U.S. Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 86 U.S. Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 87 U.S. Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 88 U.S. Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 89 U.S. Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 90 U.S. Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 91 U.S. Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 92 U.S. Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 93 U.S. Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 94 U.S. Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 95 U.S. Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 96 U.S. Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 97 U.S. Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 98 U.S. Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 99 U.S. Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 100 U.S. Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 101 U.S. C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 102 U.S. Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 103 U.S. Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 104 U.S. Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 105 U.S. Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 106 U.S. Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 107 U.S. Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 108 U.S. Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 109 U.S. Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 110 Canada Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 111 Canada Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 112 Canada Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 113 Canada Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 114 Canada Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 115 Canada Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 116 Canada Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 117 Canada Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 118 Canada Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 119 Canada Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 120 Canada Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 121 Canada Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 122 Canada Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 123 Canada Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 124 Canada Albumin (Plasma Volume Expander) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 125 Canada Protease Inhibitors (For Genetic Deficiencies) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 126 Canada Alpha 1 Antitrypsin (Aat) (For Aat Deficiency) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 127 Canada C1 Esterase Inhibitor (C1 Inh) (For Hae) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 128 Canada Monoclonal Antibodies (Derived From Plasma Cells) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 129 Canada Other Plasma Derived Proteins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 130 Canada Antithrombin Iii (At Iii) (For Thrombosis Prevention) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 131 Canada Blood Plasma & Plasma Derived Medicinal Products Market, By Application, 2018-2032 (Usd Thousand)
- Table 132 Canada Blood Plasma & Plasma Derived Medicinal Products Market, By Processing Technology, 2018-2032 (Usd Thousand)
- Table 133 Canada Blood Plasma & Plasma Derived Medicinal Products Market, By Mode, 2018-2032 (Usd Thousand)
- Table 134 Canada Blood Plasma & Plasma Derived Medicinal Products Market, By End User, 2018-2032 (Usd Thousand)
- Table 135 Canada Blood Plasma & Plasma Derived Medicinal Products Market, By Distribution Channel, 2018-2032 (Usd Thousand)
- Table 136 Mexico Blood Plasma & Plasma Derived Medicinal Products Market, By Product, 2018-2032 (Usd Thousand)
- Table 137 Mexico Immunoglobulins In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 138 Mexico Intravenous Immunoglobulins (Ivigs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 139 Mexico Intramuscular Immunoglobulins (Imig) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 140 Mexico Coagulation Factors (For Bleeding Disorders) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 141 Mexico Factor Ix Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 142 Mexico Recombinant Factor Ix (Rfix) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 143 Mexico Factor Viii Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 144 Mexico Recombinant Factor Viii (Rfviii) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 145 Mexico Fibrinogen Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 146 Mexico Prothrombin Complex Concentrates (Pccs) In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 147 Mexico Von Willebrand Factor (Vwf) Products In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 148 Mexico Factor Xiii Concentrates In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- Table 149 Mexico Factor Viia In Blood Plasma & Plasma Derived Medicinal Products Market, By Type, 2018-2032 (Usd Thousand)
- List Of Figures
- Figure 1 Global Blood Plasma & Plasma Derived Medicinal Products Market: Segmentation
- Figure 2 Global Blood Plasma & Plasma Derived Medicinal Products Market: Data Triangulation
- Figure 3 Global Blood Plasma & Plasma Derived Medicinal Products Market: Droc Analysis
- Figure 4 Global Blood Plasma & Plasma Derived Medicinal
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
